Table 3 Analysis of factors associated with any damage (SDI ≥1) at 18 months
Distribution of potential predictors of damage | Multivariate analysis | |||
|---|---|---|---|---|
SDI ≥1 (n = 23) | SDI = 0 (n = 84) | Odds ratio | p value | |
No LLDAS at T1, n (%) | 19 (82.6%) | 41 (48.8%) | 5.0 (1.5–16.6) | 0.009 |
No LLDAS at T2, n (%) | 18 (78.3%) | 41 (48.8%) | - | - |
Male gender, n (%) | 3 (13.0%) | 8 (9.5%) | - | - |
Diagnosis age, median (IQR) years | 39.4 (34.2–52.9) | 31.9 (25.6–41.6) | 1.05 (1.01–1.09) | 0.020 |
Disease duration, median (IQR) months | 9.9 (4.9–36.0) | 9.6 (6.2–25.0) | - | - |
Renal involvement, n (%) | 9 (39.1%) | 18 (21.4%) | - | - |
PDN, mg/day median (IQR) | 16.7 (11.0–23.2) | 8.4 (5.0–16.7) | - | - |
Anti-malarial drugs, n (%) | 9 (39.1%) | 57 (67.9%) | - | - |
Immunosuppressant drugs, n (%) | 17 (73.9%) | 57 (67.9%) | - | - |